DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ribavirin

Ribavirin

  • Effectiveness and Safety of Sofosbuvir Plus Ribavirin for the Treatment of HCV Genotype 2 Infection

    Effectiveness and Safety of Sofosbuvir Plus Ribavirin for the Treatment of HCV Genotype 2 Infection

  • Anti-Inflammatory Effects of Amantadine and Memantine

    Anti-Inflammatory Effects of Amantadine and Memantine

  • Antiviral Agents Active Against Influenza a Viruses

    Antiviral Agents Active Against Influenza a Viruses

  • Ribavirin) Tablets Initial U.S

    Ribavirin) Tablets Initial U.S

  • OLYSIO (Simeprevir) Capsules, for Oral Use Ribavirin May Cause Birth Defects and Fetal Death and Animal Studies Initial U.S

    OLYSIO (Simeprevir) Capsules, for Oral Use Ribavirin May Cause Birth Defects and Fetal Death and Animal Studies Initial U.S

  • Viraferon, INN-Interferon Alfa-2B

    Viraferon, INN-Interferon Alfa-2B

  • Taribavirin.Pdf

    Taribavirin.Pdf

  • Antiviral Efficacy of Ribavirin and Favipiravir Against Hantaan Virus

    Antiviral Efficacy of Ribavirin and Favipiravir Against Hantaan Virus

  • HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use LAMIVUDINE and TENOFOVIR

    HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use LAMIVUDINE and TENOFOVIR

  • Comprehensive Analysis of Drugs to Treat SARS‑Cov‑2 Infection: Mechanistic Insights Into Current COVID‑19 Therapies (Review)

    Comprehensive Analysis of Drugs to Treat SARS‑Cov‑2 Infection: Mechanistic Insights Into Current COVID‑19 Therapies (Review)

  • Longitudinal Analysis of the Utility of Liver Biochemistry in Hospitalised COVID-19 Patients As Prognostic Markers

    Longitudinal Analysis of the Utility of Liver Biochemistry in Hospitalised COVID-19 Patients As Prognostic Markers

  • AVT Figure Template

    AVT Figure Template

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Olysio® (Simeprevir), Sovaldi® (Sofosbuvir), & Ribavirin Treatment Agreement

    Olysio® (Simeprevir), Sovaldi® (Sofosbuvir), & Ribavirin Treatment Agreement

  • Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

    Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

  • INTRON A, Interferon Alfa-2B

    INTRON A, Interferon Alfa-2B

  • Protease Inhibitors (Ritonavir and ASC09) in Clinical Trials to Treat COVID-19, the Illness Caused by the New Coronavirus (Table 1)

    Protease Inhibitors (Ritonavir and ASC09) in Clinical Trials to Treat COVID-19, the Illness Caused by the New Coronavirus (Table 1)

  • Simeprevir (Olysio)

    Simeprevir (Olysio)

Top View
  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
  • REBETOL Safely and Effectively
  • Comparative Effectiveness and Safety of Ribavirin Plus Interferon
  • Ribavirin Information for Patients
  • In Vitro Combination Studies of Tenofovir and Other Nucleoside Analogues with Ribavirin Against HIV-1 Nicolas a Margot and Michael D Miller*
  • Impact of Repurposed Drugs on the Symptomatic COVID-19 Patients
  • Antiviral Therapeutic Approaches for SARS-Cov-2 Infection: a Systematic Review
  • Pegasys, INN-Peginterferon Alfa-2A
  • HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use MAVYRET Safely and Effec
  • Simeprevir (Olysio ™) UTILIZATION MANAGEMENT CRITERIA
  • Pegylated Interferon Alpha 2A
  • PEGASYS Prescribing Information
  • These Highlights Do Not Include All the Information Needed to Use RIBAVIRIN TABLETS Safely and Effectively
  • ZEPATIER Is Recommended
  • Ribavirin Teva, INN-Ribavirin
  • NDA 21-356/S-011 Page 4 VIREAD (Tenofovir Disoproxil Fumarate)
  • Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence
  • Pegasys (Peginterferon Alfa-2A) Label


© 2024 Docslib.org    Feedback